Thrombopoietin Receptor Agonists Market Share

On the basis of regional analysis, the thrombopoietin receptor agonist market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Based on this, the market in North America industry is poised to account for largest revenue share by 2036, attributed to rising awareness of the rare blood disorders, advanced healthcare facilities, easier access to the treatment of ITP and higher investment in research and development activities. In addition, the market in Asia Pacific is expected to record the highest CAGR over the forecast period owing to increasing economic growth and rising awareness of the rare blood disorders among people in the region.